Telemedicine is a relatively new branch of modern medicine which represents the opportunity to connect the most secluded and high-risk patients with leading specialists in large medical centers. The advantages of telemedicine are reach, low cost and fast workflow. Ophthalmology is especially suited to a telemedical approach because of the nature of diagnostics in this branch of medicine, which mostly relies on images and external observation. The COVID-19 pandemic has kickstarted and accelerated the development and adoption of new technologies relating to telemedicine. However, telemedicine isn't widely accepted, mostly among older patients. Because of this, a combined approach using traditional and telemedical methods is ideal, depending on the wishes and circumstances of the patient. Application of telemedicine in ophthalmology has already been accepted and put into standard practice in select countries, and is most commonly used for screening for diabetic retinopathy, age related macular degeneration, retinopathy of prematurity, cataracts and glaucoma. These programs have been proven to be just as effective as in-person examinations, and as such are used more and more. Apart from screening, teleophthalmology can be used for diagnostics, follow-up exams, consultations, and illness progression assessment. Artificial intelligence application is a relatively new phenomenon within teleophthalmology, but it is showing promising results. Artificial intelligence can successfully perform specific tasks comparatively well to ophthalmology specialists, however, a hybrid approach consisting of a specialist and artificial intelligence cooperating has proven to be the most successful. Furthermore, artificial intelligence has the potential to do things doctors cannot, such as cardiovascular risk assessment using only fundus images.